Application of Allometric Scaling and Translational Modeling to Predict Human Pharmacokinetics of mRNA-Encoded Antibodies
{{output}}
Messenger RNA (mRNA)-lipid nanoparticle (mRNA-LNP) platforms enable the in vivo expression of almost any therapeutic protein, offering unprecedented flexibility for clinical translation. However, for these rapidly deployable therapies, predicting the first-in-... ...
